Sinopharm Group Co. Ltd. (SHTDY) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Sinopharm Group Co. Ltd.

    OTC: SHTDY · Real-Time Price · USD
    12.18
    0.23 (1.96%)
    At close: Sep 11, 2025, 10:46 AM

    Sinopharm Cash Flow Statement

    Financials in CNY. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 14B 19.51B 18.56B 17B
    Depreciation & Amortization
    		 4.73B 4.43B 4.17B 3.92B
    Stock-Based Compensation
    		 n/a n/a n/a n/a
    Other Working Capital
    		 n/a 10.53B 7.43B -7.76B
    Other Non-Cash Items
    		 -7.19B -2.9B 308.65M 484.2M
    Deferred Income Tax
    		 n/a n/a n/a n/a
    Change in Working Capital
    		 n/a -3.86B -2.07B -12.1B
    Operating Cash Flow
    		 11.55B 17.17B 20.96B 9.31B
    Capital Expenditures
    		 -1.97B -2.34B -2.42B -2.26B
    Cash Acquisitions
    		 n/a -31.86M -336.71M -488.36M
    Purchase of Investments
    		 n/a -29.07M -100M -75M
    Sales Maturities Of Investments
    		 n/a 53.06M 211.53M 298.63M
    Other Investing Acitivies
    		 -1.29B 1.02B -946.91M 1.25B
    Investing Cash Flow
    		 -3.75B -944.53M -3.59B -1.27B
    Debt Repayment
    		 n/a 2.5B 4.75B -4.79B
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a -2.56B -2.34B -2.15B
    Other Financial Acitivies
    		 -17.29B -7.59B -8.1B -7.75B
    Financial Cash Flow
    		 -17.29B -7.64B -5.69B -14.69B
    Net Cash Flow
    		 -9.5B 8.59B 11.69B -6.65B
    Free Cash Flow
    		 9.58B 14.84B 18.55B 7.05B

    Add to Watchlist